Literature DB >> 6348146

[Proposed treatment of the Urrets-Zavalia syndrome. A propos of one reversible case].

F Lagoutte, P Thienpont, P Comte.   

Abstract

Regression of Urrets-Zavalia's syndrome was obtained in one case after treatment administered according to a strict sequence following keratoplasty for keratoconus: sympatholytic drops (guanethidine 5%-Ismelin) every 4 hours for 24 hours, followed the next day, when mydriasis had been slightly reduced, by parasympathomimetic drops (pilocarpine 2%). Marked myosis was observed and treatment discontinued. This resulted in recurrence of the mydriasis, but this was successfully treated by repeating therapy. Pilocarpine drops were progressively diminished, followed by a slow reduction of guanethidine drops over 8 weeks, resulting in only slight residual anisocoria. This treatment is based on the physiopathological concept of sympathetic spasm with parasympathetic inhibition, and it is suggested that reduction of spasm should be obtained before administration of therapy to stimulate the sphincter. Pharmacological data on the compounds employed are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348146

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  Urrets-Zavalia syndrome after implantable Collamer lens placement.

Authors:  Ahmed Al Habash; Khalid Al Arfaj; Omar Al Abdulsalam
Journal:  Digit J Ophthalmol       Date:  2015-09-30

2.  Urrets-Zavalia syndrome following cataract surgery in dogs: A case series.

Authors:  Francisco Cantero; Marta Leiva; Laura Gaztelu; Irene Cerrada; Rita Vilao Cardoso; Teresa Peña
Journal:  Open Vet J       Date:  2022-02-26

3.  Regression of urrets-zavalia syndrome after deep lamellar keratoplasty for keratoconus: a case study.

Authors:  Leopoldo Spadea; Mariangela Viola; Giovanna Viola
Journal:  Open Ophthalmol J       Date:  2008-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.